BioNTech (Germany) Technical Analysis
| 22UA Stock | EUR 91.85 1.25 1.34% |
As of the 27th of February, BioNTech shows the Mean Deviation of 1.94, risk adjusted performance of 0.0522, and Downside Deviation of 2.44. BioNTech SE technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioNTech SE downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if BioNTech SE is priced correctly, providing market reflects its regular price of 91.85 per share.
BioNTech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioNTech, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioNTechBioNTech |
BioNTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioNTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioNTech.
| 11/29/2025 |
| 02/27/2026 |
If you would invest 0.00 in BioNTech on November 29, 2025 and sell it all today you would earn a total of 0.00 from holding BioNTech SE or generate 0.0% return on investment in BioNTech over 90 days. BioNTech is related to or competes with China Construction, PT Bank, NVIDIA CORP, APPLE INC, and AMAZON INCCDR. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseas... More
BioNTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioNTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioNTech SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.44 | |||
| Information Ratio | 0.0249 | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (3.62) | |||
| Potential Upside | 4.12 |
BioNTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioNTech's standard deviation. In reality, there are many statistical measures that can use BioNTech historical prices to predict the future BioNTech's volatility.| Risk Adjusted Performance | 0.0522 | |||
| Jensen Alpha | 0.1731 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0269 | |||
| Treynor Ratio | (0.42) |
BioNTech February 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0522 | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 1.94 | |||
| Semi Deviation | 2.21 | |||
| Downside Deviation | 2.44 | |||
| Coefficient Of Variation | 1695.34 | |||
| Standard Deviation | 2.64 | |||
| Variance | 6.95 | |||
| Information Ratio | 0.0249 | |||
| Jensen Alpha | 0.1731 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0269 | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (3.62) | |||
| Potential Upside | 4.12 | |||
| Downside Variance | 5.96 | |||
| Semi Variance | 4.9 | |||
| Expected Short fall | (2.09) | |||
| Skewness | 0.8946 | |||
| Kurtosis | 2.71 |
BioNTech SE Backtested Returns
At this point, BioNTech is very steady. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.0713, which signifies that the company had a 0.0713 % return per unit of risk over the last 3 months. We have found thirty technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please confirm BioNTech's Risk Adjusted Performance of 0.0522, downside deviation of 2.44, and Mean Deviation of 1.94 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%. BioNTech has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.35, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioNTech are expected to decrease at a much lower rate. During the bear market, BioNTech is likely to outperform the market. BioNTech SE right now shows a risk of 2.58%. Please confirm BioNTech SE standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if BioNTech SE will be following its price patterns.
Auto-correlation | -0.51 |
Good reverse predictability
BioNTech SE has good reverse predictability. Overlapping area represents the amount of predictability between BioNTech time series from 29th of November 2025 to 13th of January 2026 and 13th of January 2026 to 27th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioNTech SE price movement. The serial correlation of -0.51 indicates that about 51.0% of current BioNTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.51 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 13.06 |
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioNTech SE Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for BioNTech SE across different markets.
About BioNTech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioNTech SE on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioNTech SE based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioNTech SE price pattern first instead of the macroeconomic environment surrounding BioNTech SE. By analyzing BioNTech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioNTech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioNTech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0123 | 0.011 | Price To Sales Ratio | 10.92 | 10.38 |
BioNTech February 27, 2026 Technical Indicators
Most technical analysis of BioNTech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioNTech from various momentum indicators to cycle indicators. When you analyze BioNTech charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0522 | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 1.94 | |||
| Semi Deviation | 2.21 | |||
| Downside Deviation | 2.44 | |||
| Coefficient Of Variation | 1695.34 | |||
| Standard Deviation | 2.64 | |||
| Variance | 6.95 | |||
| Information Ratio | 0.0249 | |||
| Jensen Alpha | 0.1731 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0269 | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (3.62) | |||
| Potential Upside | 4.12 | |||
| Downside Variance | 5.96 | |||
| Semi Variance | 4.9 | |||
| Expected Short fall | (2.09) | |||
| Skewness | 0.8946 | |||
| Kurtosis | 2.71 |
BioNTech February 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioNTech stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 32.85 | ||
| Daily Balance Of Power | (0.64) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 92.53 | ||
| Day Typical Price | 92.30 | ||
| Price Action Indicator | (1.30) | ||
| Market Facilitation Index | 0 |
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |